# pathway_0101

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **B** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MTFIIAVVGATGNQGGSVARSLVQNPSFSVRAITRSPDSQASRSLLSAGAEVVKADGFNGEEMLAAFQGAWGAFVNLNSDDPIWRQPGGPTEFDLGKTIVDAAAGAGVKHLVFSSGPPCVEMTGGKVNMKAMEMKYKIEQYARKLGSFETLTPINPAWYLENFLAEEVAPIFGGFPYFPDEEGYLTFRVPHWAGPGGDNRVPFLGIRDDFGDIIHGIFLNPERYNGRVIHGVSQLRGFDELVADFEQVTGKKCRYEPVLPSWEAFDIHGIPELEDVKLMFAFTQTTGGRYFAPEPSEADTAAELKRTTAVALGKPEPEQHTLRTKDFFRKHFATEK

[Multiple Choices]
A. Polyketide biosynthesis. .
B. Secondary metabolite biosynthesis. .
C. Pigment biosynthesis. .
D. 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact supplied sequence matches the UniProt entry annotated with the pathway “Secondary metabolite biosynthesis.” The annotation is linked to PubMed 33372776 with evidence code ECO:0000269; this supports the key, though the cited paper was not independently assessed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a concrete basis to distinguish this protein's specific pathway from the choices. Its pathway role depends on protein-specific functional context.


**Missing item-specific fact**

> That this sequence is FrzB, a protein in the FR901483 biosynthesis cluster, with a pathway annotation of secondary metabolite biosynthesis.


**Reason**

> The sequence and choices do not disclose the protein's pathway assignment. Recognizing the sequence or consulting its annotation could identify the answer, but that is an item-specific fact not supplied in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence supports the stated secondary-metabolite pathway. Although polyketide and pigment biosynthesis can be forms of secondary-metabolite biosynthesis in general, the supplied evidence does not place this protein in either specific pathway; the folate option is also unsupported.


### Important caveats

- The reviewer-only source establishes a sequence-matched annotation, not information available to the evaluated model.
- The annotation cites experimental evidence, but the cited paper was not independently retrieved and validated here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a concrete basis to distinguish this protein's specific pathway from the choices. Its pathway role depends on protein-specific functional context.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this sequence is FrzB, a protein in the FR901483 biosynthesis cluster, with a pathway annotation of secondary metabolite biosynthesis.",
    "reason": "The sequence and choices do not disclose the protein's pathway assignment. Recognizing the sequence or consulting its annotation could identify the answer, but that is an item-specific fact not supplied in the question."
  },
  "case_id": "pathway_0101",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry annotated with the pathway “Secondary metabolite biosynthesis.” The annotation is linked to PubMed 33372776 with evidence code ECO:0000269; this supports the key, though the cited paper was not independently assessed here."
  },
  "important_caveats": [
    "The reviewer-only source establishes a sequence-matched annotation, not information available to the evaluated model.",
    "The annotation cites experimental evidence, but the cited paper was not independently retrieved and validated here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports the stated secondary-metabolite pathway. Although polyketide and pigment biosynthesis can be forms of secondary-metabolite biosynthesis in general, the supplied evidence does not place this protein in either specific pathway; the folate option is also unsupported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0101",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry annotated with the pathway “Secondary metabolite biosynthesis.” The annotation is linked to PubMed 33372776 with evidence code ECO:0000269; this supports the key, though the cited paper was not independently assessed here.",
    "evidence_ids": ["C5", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a concrete basis to distinguish this protein's specific pathway from the choices. Its pathway role depends on protein-specific functional context.",
    "missing_item_specific_fact": "That this sequence is FrzB, a protein in the FR901483 biosynthesis cluster, with a pathway annotation of secondary metabolite biosynthesis.",
    "reason": "The sequence and choices do not disclose the protein's pathway assignment. Recognizing the sequence or consulting its annotation could identify the answer, but that is an item-specific fact not supplied in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports the stated secondary-metabolite pathway. Although polyketide and pigment biosynthesis can be forms of secondary-metabolite biosynthesis in general, the supplied evidence does not place this protein in either specific pathway; the folate option is also unsupported."
  },
  "important_caveats": [
    "The reviewer-only source establishes a sequence-matched annotation, not information available to the evaluated model.",
    "The annotation cites experimental evidence, but the cited paper was not independently retrieved and validated here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A7T8F1M6 (sequence exactly matched) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269|PubMed:33372776, the 2021 JACS paper on FR901483 biosynthesis). The protein is FrzB, an NmrA-like oxidoreductase in the FR901483 (immunosuppressant) biosynthetic cluster. The author's key matches the curated annotation.

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The NmrA-like domain and Rossmann-fold NAD(P)-binding motif (GATGNQGGS...) suggest association with secondary metabolism regulation, and the fungal origin (Cladobotryum) is consistent with secondary metabolite production. One could weakly argue that NmrA-like regulators are not polyketide-specific (PKS enzymes have KS/AT/ACP domains) nor pigment-specific, making the broad 'Secondary metabolite biosynthesis' label a reasonable umbrella. However, this argument is indirect and does not exclude polyketide or pigment sub-pathways with confidence.


**Missing item-specific fact**

> Knowledge that this protein (FrzB) belongs specifically to the FR901483 biosynthetic cluster (a non-ribosomal peptide/terpenoid hybrid immunosuppressant, not a polyketide or pigment) is required to definitively assign 'Secondary metabolite biosynthesis' over the more specific subcategories 'Polyketide biosynthesis' or 'Pigment biosynthesis.' The sequence alone does not reveal the specific metabolite class.


**Reason**

> While the NmrA-like domain provides a general pointer toward secondary metabolism, distinguishing the broad category (B) from the narrower secondary-metabolism subcategories (A: polyketide, C: pigment) from sequence alone is not reliably possible. The correct answer depends on knowing the specific biosynthetic cluster identity, which is a database/experimental annotation fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B",
  "C"
]
```

> Polyketide biosynthesis, pigment biosynthesis, and secondary metabolite biosynthesis are all subcategories or overlapping categories of secondary metabolism. Without knowing the specific metabolite (FR901483, a non-polyketide), a model reasoning from the NmrA-like domain could plausibly select any of these three. Option D (folate biosynthesis/DHPS) is clearly distinguishable by fold and sequence.


### Important caveats

- The UniProt pathway annotation is supported by experimental evidence (ECO:0000269) from the 2021 JACS paper, not merely computational inference.
- The NmrA-like domain is classically a transcriptional regulator of secondary metabolism in actinomycetes; its role here as an oxidoreductase with catalytic function in a fungal cluster is a newer finding.
- The question's answer key uses the broad UniProt pathway term 'Secondary metabolite biosynthesis' rather than a more specific sub-pathway, which is the UniProt curation choice for this entry.
- The accession and pathway annotation were absent from the evaluated model's input; only the raw sequence and four choices were provided.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The NmrA-like domain and Rossmann-fold NAD(P)-binding motif (GATGNQGGS...) suggest association with secondary metabolism regulation, and the fungal origin (Cladobotryum) is consistent with secondary metabolite production. One could weakly argue that NmrA-like regulators are not polyketide-specific (PKS enzymes have KS/AT/ACP domains) nor pigment-specific, making the broad 'Secondary metabolite biosynthesis' label a reasonable umbrella. However, this argument is indirect and does not exclude polyketide or pigment sub-pathways with confidence.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Knowledge that this protein (FrzB) belongs specifically to the FR901483 biosynthetic cluster (a non-ribosomal peptide/terpenoid hybrid immunosuppressant, not a polyketide or pigment) is required to definitively assign 'Secondary metabolite biosynthesis' over the more specific subcategories 'Polyketide biosynthesis' or 'Pigment biosynthesis.' The sequence alone does not reveal the specific metabolite class.",
    "reason": "While the NmrA-like domain provides a general pointer toward secondary metabolism, distinguishing the broad category (B) from the narrower secondary-metabolism subcategories (A: polyketide, C: pigment) from sequence alone is not reliably possible. The correct answer depends on knowing the specific biosynthetic cluster identity, which is a database/experimental annotation fact."
  },
  "case_id": "pathway_0101",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8F1M6 (sequence exactly matched) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269|PubMed:33372776, the 2021 JACS paper on FR901483 biosynthesis). The protein is FrzB, an NmrA-like oxidoreductase in the FR901483 (immunosuppressant) biosynthetic cluster. The author's key matches the curated annotation."
  },
  "important_caveats": [
    "The UniProt pathway annotation is supported by experimental evidence (ECO:0000269) from the 2021 JACS paper, not merely computational inference.",
    "The NmrA-like domain is classically a transcriptional regulator of secondary metabolism in actinomycetes; its role here as an oxidoreductase with catalytic function in a fungal cluster is a newer finding.",
    "The question's answer key uses the broad UniProt pathway term 'Secondary metabolite biosynthesis' rather than a more specific sub-pathway, which is the UniProt curation choice for this entry.",
    "The accession and pathway annotation were absent from the evaluated model's input; only the raw sequence and four choices were provided."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B",
      "C"
    ],
    "reason": "Polyketide biosynthesis, pigment biosynthesis, and secondary metabolite biosynthesis are all subcategories or overlapping categories of secondary metabolism. Without knowing the specific metabolite (FR901483, a non-polyketide), a model reasoning from the NmrA-like domain could plausibly select any of these three. Option D (folate biosynthesis/DHPS) is clearly distinguishable by fold and sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0101",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8F1M6 (sequence exactly matched) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269|PubMed:33372776, the 2021 JACS paper on FR901483 biosynthesis). The protein is FrzB, an NmrA-like oxidoreductase in the FR901483 (immunosuppressant) biosynthetic cluster. The author's key matches the curated annotation.",
    "evidence_ids": ["C5", "C4", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The NmrA-like domain and Rossmann-fold NAD(P)-binding motif (GATGNQGGS...) suggest association with secondary metabolism regulation, and the fungal origin (Cladobotryum) is consistent with secondary metabolite production. One could weakly argue that NmrA-like regulators are not polyketide-specific (PKS enzymes have KS/AT/ACP domains) nor pigment-specific, making the broad 'Secondary metabolite biosynthesis' label a reasonable umbrella. However, this argument is indirect and does not exclude polyketide or pigment sub-pathways with confidence.",
    "missing_item_specific_fact": "Knowledge that this protein (FrzB) belongs specifically to the FR901483 biosynthetic cluster (a non-ribosomal peptide/terpenoid hybrid immunosuppressant, not a polyketide or pigment) is required to definitively assign 'Secondary metabolite biosynthesis' over the more specific subcategories 'Polyketide biosynthesis' or 'Pigment biosynthesis.' The sequence alone does not reveal the specific metabolite class.",
    "reason": "While the NmrA-like domain provides a general pointer toward secondary metabolism, distinguishing the broad category (B) from the narrower secondary-metabolism subcategories (A: polyketide, C: pigment) from sequence alone is not reliably possible. The correct answer depends on knowing the specific biosynthetic cluster identity, which is a database/experimental annotation fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B", "C"],
    "reason": "Polyketide biosynthesis, pigment biosynthesis, and secondary metabolite biosynthesis are all subcategories or overlapping categories of secondary metabolism. Without knowing the specific metabolite (FR901483, a non-polyketide), a model reasoning from the NmrA-like domain could plausibly select any of these three. Option D (folate biosynthesis/DHPS) is clearly distinguishable by fold and sequence."
  },
  "important_caveats": [
    "The UniProt pathway annotation is supported by experimental evidence (ECO:0000269) from the 2021 JACS paper, not merely computational inference.",
    "The NmrA-like domain is classically a transcriptional regulator of secondary metabolism in actinomycetes; its role here as an oxidoreductase with catalytic function in a fungal cluster is a newer finding.",
    "The question's answer key uses the broad UniProt pathway term 'Secondary metabolite biosynthesis' rather than a more specific sub-pathway, which is the UniProt curation choice for this entry.",
    "The accession and pathway annotation were absent from the evaluated model's input; only the raw sequence and four choices were provided."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8F1M6` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 12. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M6.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.906105+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis cluster protein B"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"1.5.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"NmrA-like family domain-containing oxidoreductase FrzB"}}}
```

Source SHA-256: `26631434aec4fabf8eb05f0a928e2ab6e7506f73e2486f63ad06a9a7ab4d6c22`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M6.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.906105+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"Secondary metabolite biosynthesis"}]}
```

Source SHA-256: `26631434aec4fabf8eb05f0a928e2ab6e7506f73e2486f63ad06a9a7ab4d6c22`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M6.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:48.906105+00:00.  

```json
{"citation":{"authors":["Zhang Z.","Tamura Y.","Tang M.","Qiao T.","Sato M.","Otsu Y.","Sasamura S.","Taniguchi M.","Watanabe K.","Tang Y."],"citationCrossReferences":[{"database":"PubMed","id":"33372776"},{"database":"DOI","id":"10.1021/jacs.0c12352"}],"citationType":"journal article","firstPage":"132","id":"33372776","journal":"J. Am. Chem. Soc.","lastPage":"136","publicationDate":"2021","title":"Biosynthesis of the Immunosuppressant (-)-FR901483.","volume":"143"},"referenceComments":[{"type":"STRAIN","value":"11231"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `26631434aec4fabf8eb05f0a928e2ab6e7506f73e2486f63ad06a9a7ab4d6c22`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M6?format=txt&versions=12)  
**Locator:** `lines 14-22`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 12 / 1.  
**Retrieved:** 2026-11-02T04:25:51.134889+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=11231;
RX   PubMed=33372776; DOI=10.1021/jacs.0c12352;
RA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,
RA   Taniguchi M., Watanabe K., Tang Y.;
RT   "Biosynthesis of the Immunosuppressant (-)-FR901483.";
RL   J. Am. Chem. Soc. 143:132-136(2021).
```

Source SHA-256: `ee1a2be9be3ccf677aecb6332a99ec11ea500e17cc26c192f117732e78966d27`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M6?format=txt&versions=12)  
**Locator:** `lines 63-64`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 12 / 1.  
**Retrieved:** 2026-11-02T04:25:51.134889+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `ee1a2be9be3ccf677aecb6332a99ec11ea500e17cc26c192f117732e78966d27`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 101. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
